Genome Editing Market to Reach Over USD 3200 Billion by 2032
Growing Pharmaceutical Use and Drug Discovery Boosting Market
London, August 2024
According to a report published by The Brainy Insights, the global genome editing market size is expected to reach a staggering USD 3204 billion by 2032. The market, which stood at USD 78 billion in 2023, is projected to grow by USD 723 billion between 2023 and 2028, a remarkable CAGR of 1588%.
The growth is primarily driven by the expanding use of gene editing in various drug discovery processes. Pharmaceutical companies are increasingly utilizing genome editing to develop more effective and personalized treatments for a broad range of diseases. Additionally, the CAGR of 17% during 2020-2024, highlights the rapid adoption of genome editing technologies.
Comments